Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement PBYI Q1 2026 Earnings EPS Surprise of 4721 as Narrowed Loss Beats Estimates XPON Q2 2025 Earnings Strong EPS Beat Highlights Cost Discipline BBNX Q1 2026 Earnings NarrowerthanExpected Loss Drives DoubleDigit Stock Surge CRDL Q4 2025 Earnings Loss Narrows as EPS Beats Estimates by 142 SABS Q1 2026 Earnings Widening Losses Amid PreRevenue Status